BackRegenxbio Overview

Regenxbio Total Liabilities

Track Regenxbio's total liabilities ($310M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$314.85M
14.29% YoYΔ $-52.49M vs prior year quarter

Peer trimmed avg / median

Loading

Regenxbio Total Liabilities History

Loading

Regenxbio vs. peers: Total Liabilities Comparison

Loading

Regenxbio Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Regenxbio (RGNX) FAQ

As of the most recent data (June 2026), RGNX shows a total liabilities of $310M. That compares with $370M in the prior-year period — down 14.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RGNX's total liabilities is now $310M (was $370M) — a 14.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Regenxbio is outperforming or lagging.

Tracking RGNX's total liabilities over time shows whether Regenxbio is scaling, shrinking, or reshaping that part of the business. The current reading is $310M That compares with $370M in the prior-year period — down 14.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Regenxbio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $310M) with ownership activity and broader fundamentals.

Regenxbio's total liabilities is $310M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.